William Pao
Director/Board Member chez Transcelerate Biopharma, Inc.
Fortune : 3 M $ au 31/03/2024
Profil
William Pao is the founder of My Cancer Genome.
He currently holds director positions at the American Association for Cancer Research and Transcelerate Biopharma, Inc. Previously, he was a professor and director of Hematology & Oncology Division at Vanderbilt University, and director of Personalized Cancer Medicine at The Vanderbilt-Ingram Cancer Center.
He also served as Head of Pharma Research & Early Development at Roche Holding AG.
Pao holds an undergraduate degree from Harvard University and a doctorate from Yale University.
He will serve as Chief Development Officer & Executive VP at Pfizer Inc. in 2022.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PFIZER INC.
0,00% | 31/03/2023 | 97 765 ( 0,00% ) | 3 M $ | 31/03/2024 |
Postes actifs de William Pao
| Sociétés | Poste | Début |
|---|---|---|
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Anciens postes connus de William Pao
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 15/08/2023 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 18/03/2022 |
| My Cancer Genome | Founder | - |
The Vanderbilt-Ingram Cancer Center
 The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Corporate Officer/Principal | - |
| Vanderbilt University | Corporate Officer/Principal | - |
Formation de William Pao
| Harvard University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 4 |
|---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Health Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
| My Cancer Genome |
